Prime Medicine, Inc. (PRME) Revenue 2020–2025
Prime Medicine, Inc. (PRME) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.6MFY2025 · since FY2020: $5.2M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.6M | +55.3% |
| FY2024 | $3.0M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $5.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating incomePRME Operating marginPRME Operating cash flowPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →